ASCN yields 3.58% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, ASCN + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASCN + ABBV for your $10,000?
Absecon Bancorp operates as the bank holding company for The First National Bank of Absecon that provides various personal and business banking products and services primarily in Atlantic County, New Jersey. It offers checking, NOW, money market, and savings accounts; certificates of deposit; individual retirement accounts; and credit card merchant accounts. The company also provides consumer loans, including secured and unsecured personal loans, new and used vehicle loans, fixed rate home equity loans, and home equity lines of credit; and mortgages, such as fixed rate mortgages, construction mortgages, and mortgage programs for investment properties and second homes, as well as land purchase loans. In addition, it offers commercial mortgages, business lines of credit, accounts receivable/inventory financing, letters of credit, equipment financing, and demand loans. Further, the company provides credit card merchant processing services, wire transfers, direct deposits, night deposits, telephone and Internet banking services, and personal overdraft protection services. It primarily operates offices in Absecon, Galloway Township, and Northfield in Atlantic County, as well as provides services in portions of Burlington, Cape May, and Ocean Counties, New Jersey. Absecon Bancorp was founded in 1916 and is based in Absecon, New Jersey.
Full ASCN Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.